The mark consists of the word "DUDE" with a curved line and a dot over the second "D". Above the word "DUDE" is the phrase "ACCESS SERVICES" and below that is the phrase "Darolutamide User Drug Experience".
Mark For: DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE™ trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of the word "DUDE" with a curved line and a dot over the second "D". Above the word "DUDE" is the phrase "ACCESS SERVICES" and below that is the phrase "Darolutamide User Drug Experience".
Research | OneLook Acronym Finder |
Serial Number | 88537082 |
Mark Literal Elements | DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-02-04 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Christopher J. McHattie, Esq. |
Law Office Assigned | L40 |
Employee Name | NUNLEY, CHRISTOPHER M |
2019-07-25 | Application Filed |
2019-11-07 | Location: PUBLICATION AND ISSUE SECTION |
2019-12-10 | Published |
2019-12-10 | Published for Opposition |
2019-12-10 | Status: Live/Pending |
2019-12-27 | Transaction Date |
2020-02-04 | Location: INTENT TO USE SECTION |
2020-02-04 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
Party: | Bayer HealthCare Pharmaceuticals Inc. |
Address | 100 Bayer Boulevard Whippany, NEW JERSEY UNITED STATES 07981 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DELAWARE |
Drawing | IMAGE/JPEG | 2019-07-25 |
TEAS RF New Application | MULTI | 2019-07-25 |
Design Search Code Corr Project | APPLICATION/XML | 2019-08-03 |
Examiners Amendment Priority | MULTI | 2019-08-22 |
XSearch Search Summary | APPLICATION/XML | 2019-08-22 |
Response to Office Action | APPLICATION/XML,IMAGE/JPEG | 2019-10-28 |
Amendment and Mail Process Complete | MULTI | 2019-11-07 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-11-08 |
Notice of Publication | XML | 2019-11-20 |
Notification Of Notice of Publication | XML | 2019-11-20 |
OG Publication Confirmation | APPLICATION/XML | 2019-12-10 |
Notice of Allowance | APPLICATION/XML | 2020-02-04 |
26.17.02 | Bands, wavy; Bars, wavy; Lines, wavy; Wavy line(s), band(s) or bar(s) |
26.17.06 | Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal |
260121 | Circles that are totally or partially shaded. |
261702 | Bands, wavy; Bars, wavy; Lines, wavy; Wavy line(s), band(s) or bar(s) |
261706 | Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal |
IC 036. US 100 101 102. G & S: Financial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs
International Codes: | 36 |
U.S. Codes: | 100,101,102 |
Type Code | Type |
---|---|
CC0000 | Color is not claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-02-04 | |
PUBLISHED FOR OPPOSITION | 2019-12-10 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-12-10 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-11-20 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-11-07 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-11-06 | 70633 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-11-06 | 70633 |
ASSIGNED TO LIE | 2019-11-04 | 70633 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-10-28 | |
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2019-08-22 | 6326 |
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | 2019-08-22 | 92457 |
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2019-08-22 | 6326 |
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | 2019-08-22 | 92457 |
ASSIGNED TO EXAMINER | 2019-08-19 | 92457 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2019-08-03 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-08-02 | |
NEW APPLICATION ENTERED IN TRAM | 2019-07-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.